SCHEMBL30747360

SCHEMBL30747360

O=C1NCCC(c2cccc(Cl)c2)(C2CCCC2)N1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 1/20 0.41
CHRM3 P20309 1/20 0.41
SLC6A4 P31645 3/20 0.38
SLC6A3 Q01959 3/20 0.38
ALOX5 P09917 1/20 0.37
BACE1 P56817 3/20 0.37
SLC6A9 P48067 2/20 0.36
OPRM1 P35372 1/20 0.36
OPRL1 P41146 1/20 0.36
SLC6A5 Q9Y345 1/20 0.36
ADAMTS5 Q9UNA0 2/20 0.36
MMP2 P08253 1/20 0.36
ADAM17 P78536 1/20 0.36
DPP4 P27487 3/20 0.35
DPP9 Q86TI2 3/20 0.35
DPP8 Q6V1X1 2/20 0.35
CNR2 P34972 1/20 0.35
MAPT P10636 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26649124 1.00 CHRM2 (0.41) CHRM2CHRM3SLC6A4SLC6A3ALOX5
SCHEMBL31375641 0.69 CHRM2 (0.37) CHRM2CHRM3SLC6A4SLC6A3BACE1
SCHEMBL21780752 0.68 SLC6A3 (0.43) SLC6A4SLC6A3ALOX5OPRM1OPRL1
SCHEMBL30207550 0.68 SLC6A3 (0.39) CHRM2CHRM3SLC6A4SLC6A3ALOX5
SCHEMBL31098700 0.68 SLC6A3 (0.39) CHRM2CHRM3SLC6A4SLC6A3ALOX5
SCHEMBL31098644 0.68 SLC6A3 (0.39) CHRM2CHRM3SLC6A4SLC6A3ALOX5
SCHEMBL27173342 0.68 SLC6A3 (0.39) CHRM2CHRM3SLC6A4SLC6A3ALOX5
SCHEMBL4596721 0.65 CHRM2 (0.37) CHRM2CHRM3SLC6A4SLC6A3BACE1
SCHEMBL4596366 0.65 CHRM2 (0.37) CHRM2CHRM3SLC6A4SLC6A3BACE1
SCHEMBL16409436 0.64 SLC6A3 (0.43) CHRM2CHRM3SLC6A4SLC6A3BACE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4522583-A2 PI3K ALPHA INHIBITORS AND METHODS OF USE THEREOF Relay Therapeutics, Inc. (US) 2025-03-19 EP disclosed
WO-2023220131-A2 PI3Kα INHIBITORS AND METHODS OF USE THEREOF RELAY THERAPEUTICS, INC. (US) 2023-11-16 WO disclosed